Fennec Pharmaceuticals Inc. Share Price
NASDAQ: FENC | Small CapFennec Pharmaceuticals Inc. Stock Performance
Fennec Pharmaceuticals Inc. Share Price Today
As of 30 October 2026, Fennec Pharmaceuticals Inc.'s share price is $10.94. The stock opened at $11.14, compared to its previous close of $10.87. During today's trading session, Fennec Pharmaceuticals Inc.'s share price traded between $10.80 and $11.14, with an average price of $10.97. Over the past 52 weeks, the stock has recorded a high of $13.13 and a low of $5.66. In terms of performance, Fennec Pharmaceuticals Inc.'s share price has risen by 68.88% over the last six months and is up 33.60% on a year-on-year basis.
Fennec Pharmaceuticals Inc. Share Price Chart
Fennec Pharmaceuticals Inc. Quarterly Profit & Loss
All figures in USD
Fennec Pharmaceuticals Inc. Annual Profit & Loss
All figures in USD
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Fennec Pharmaceuticals Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $10.51 | $10.88 | +2.35% |
Sep 2026 | $12.29 | $10.63 | -9.65% |
Aug 2026 | $9.85 | $11.77 | +23.32% |
Jul 2026 | $10.75 | $9.54 | -11.05% |
Jun 2026 | $9.93 | $10.72 | +8.11% |
May 2026 | $6.62 | $9.92 | +53.20% |
Apr 2026 | $6.29 | $6.47 | +5.20% |
Mar 2026 | $8.56 | $6.16 | -27.76% |
Feb 2026 | $7.48 | $8.52 | +12.40% |
Jan 2026 | $7.57 | $7.58 | -1.56% |
Dec 2025 | $8.19 | $7.70 | -5.97% |
Nov 2025 | $8.11 | $8.19 | +0.05% |